Navigation Links
AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
Date:10/3/2008

s down fats in the blood. These patients have extremely high fat levels in their blood, resulting in recurrent and potentially lethal pancreatitis as well as an increased risk of cardiovascular complications and diabetes. Currently, there exists no effective treatment or cure for this serious disease.

Glybera(R) is a gene therapy, which inserts into muscle tissue a healthy gene that restores the enzyme (lipoprotein lipase) activity required to process fat. The advantage of this therapy is its potential to cure a disease instead of just treating the symptoms.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with seven products at different stages of development.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans," "anticipates," "believes," "will," "continues," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics only. Undue reliance should not be placed on these statements because, by their nature, they are subject to known and unknown risks and can be affected by factors that are beyond the
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Incorporated Announces Third Quarter 2007 Financial Results
3. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
7. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
8. PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
9. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
10. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
11. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... AUSTIN, Texas , Aug. 21, 2014 /PRNewswire/ ... IT services company, announced today that it has ... Records (EMR) solution for Plastic Surgery and Dermatology ... provide even more value to healthcare practices using ... CEO of eRelevance Corporation. "Using information from the ...
(Date:8/21/2014)... Eisai Limited is pleased to support the Canadian Epilepsy Alliance ... in Canada . The comic book, an ... and their parents about epilepsy, the most common neurological disorder ... Canadians. Eisai is guided by a corporate philosophy known as ... is central – there was a need within the epilepsy ...
(Date:8/21/2014)... CHARLOTTE, N.C. , Aug. 21, 2014 /PRNewswire-iReach/ ... Home Medical Equipment, Inc. for the third straight ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... Yelp, Pandora, Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
... 2011 Susquehanna Growth Equity, LLC (SGE) today announced ... a provider of managed care information for the healthcare ... and interpretation of pharmaceutical and healthcare information from health ... in managed markets. In addition, it offers data collection, ...
... SILVER SPRING, Md., April 18, 2011 ... the U.S. Food and Drug Administration. I nformation in ... times for items are current as of April 18, 2011. ... FDA News & Notes does not contain any regulatory or ...
Cached Medicine Technology:Susquehanna Growth Equity Acquires MediMedia Information Technologies, LLC 2Susquehanna Growth Equity Acquires MediMedia Information Technologies, LLC 3FDA News & Notes - Week of April 18, 2011 2
(Date:8/23/2014)... August 23, 2014 The MPWMD Board of ... of AWGs as a sole source of water for commercial ... of local architect, Ron Brown of Archworks, LLC in Carmel, ... is the first time a water district in the State ... alternative water source. AWGs at this time can now ...
(Date:8/23/2014)... 2014 Pixel Film Studios, a leader of ... release of ProIntro Vol.3, a customizable title tool for ... tile just by dragging ProIntro Vol.3 in their timeline" says ... a definite time saver and i think our users will ... beautifully designed titles made with Final Cut Pro X users ...
(Date:8/23/2014)... August 23, 2014 Dealing with a drug ... challenging when the addict is a child. Adolescent addiction has ... a long time, but a new helpline is now providing ... their parents to find a real addiction recovery center. , ... a positive impact in the community. By calling (404) 975-2762, ...
(Date:8/23/2014)... Teen drug and alcohol abuse is a major ... NC. Substance abuse can happen to people of all ... alcohol dependency in higher numbers than ever before. ... but don’t know where to find professional youth rehab. ... challenge because most treatment options are designed for adults. ...
(Date:8/23/2014)... (PRWEB) August 23, 2014 Summer vacation is ... will be back in session. While shopping for school supplies ... few weeks, Batzner encourages parents and students to also spend ... “Bed bugs are excellent hitchhikers and thrive in heavily populated ... “This makes classrooms and dorms the perfect settings for bed ...
Breaking Medicine News(10 mins):Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2Health News:Expert Advice for a Bed Bug-Free School Year 2
... SAN DIEGO, CA Creating ... part of accurate future concussion assessment, according to researchers ... Sports Medicine,s Annual Meeting in San Diego. Differences in ... assessment tool were also investigated. "Our research ...
... A smaller sized hamstring graft in an anterior cruciate ligament ... revision rates, according to research presented at the American Orthopaedic ... "Hamstring grafts are commonly used in ACL reconstruction ... in diameter. Our research illustrated that when a patient was ...
... given amrubicin (Calsed) as a second-line therapy had ... survival than patients treated with topotecan (Hycamtin), according ... on Lung Cancer in Amsterdam, hosted by the ... (IASLC). , "Amrubicin showed significant improvements in tumor ...
... for lung cancer had significantly better quality of life ... significant difference in costs between the two strategies, according ... Lung Cancer in Amsterdam, hosted by the International Association ... that assessment of lymph glands using the endoscopic approach ...
... Progress in reducing colorectal cancer (CRC) mortality rates varies significantly ... progress and those in the South showing the least progress, ... burden of CRC mortality shifted from the Northeast in the ... in the mid 2000s. The decrease in CRC mortality rates ...
... , WEDNESDAY, July 6 (HealthDay News) -- The heart ... increased rates of potentially dangerous low blood pressure, a ... in 2001 to help heart failure patients breathe more ... breath. But the drug had no significant effect on ...
Cached Medicine News:Health News:Concussion baseline important for accurate future assessment in at-risk youth athletes 2Health News:Endosonography followed by surgical staging improves quality of life, according to ASTER study 2Health News:Report finds large state disparities in progress against colorectal cancer 2Health News:Study Finds Heart Failure Drug Ineffective 2Health News:Study Finds Heart Failure Drug Ineffective 3Health News:Study Finds Heart Failure Drug Ineffective 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: